Search for: "U.S. v. Howell" Results 61 - 80 of 270
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Dec 2018, 6:17 am by William Ford
Orin Kerr flagged two draft chapters he wrote on implementing the Supreme Court’s decision in Carpenter v. [read post]
8 Dec 2018, 8:00 am by Mikhaila Fogel
Elena Chacko analyzed on the Israeli Supreme Court’s recent decision in Tabish v. [read post]
20 Nov 2018, 7:16 am by David Markus
And that omission, Stuart contended, was inconsistent with Bullcoming v. [read post]
3 Nov 2018, 11:10 am by Anushka Limaye
Robert Chesney provided an in-depth analysis of the legal and policy lessons learned from Doe v. [read post]
1 Nov 2018, 6:15 am by Marty Lederman
One week from today, on Thursday, November 8 at 1:00, a panel of the U.S. [read post]
27 Oct 2018, 5:53 am by Anushka Limaye
Stephanie Zable analyzed the Supreme Court ruling in Dimaya v. [read post]
25 Oct 2018, 11:47 am by Anushka Limaye
Ingrid Wuerth argued that, in the upcoming Jam v. [read post]
25 Oct 2018, 5:00 am by Stephen Bates
Judge Howell’s views matter: As the chief judge of the U.S. [read post]
20 Oct 2018, 6:07 am by Anushka Limaye
On Thursday, Nathaniel Sobel took a look at how courts are interpreting the Supreme Court’s decision in U.S. v. [read post]
17 Oct 2018, 12:38 pm by Anushka Limaye
Jen Patja Howell posted the newest edition of the Lawfare Podcast, which centers around Benjamin Wittes and Norm Eisen’s ‘The State of Rule of Law in the U.S. [read post]
15 Oct 2018, 10:31 am by Anushka Limaye
Gunther Hellmann analyzed the effect souring U.S. [read post]
13 Oct 2018, 4:00 am by Anushka Limaye, Victoria Clark
In other ECHR news, Chinmayi Sharma summarized the court’s ruling in Big Brother Watch and Others v. the United Kingdom. [read post]
1 Oct 2018, 1:40 pm by Anushka Limaye
ICYMI: Last Weekend on Lawfare Quinta Jurecic uploaded the special counsel’s office newest brief in Miller v. [read post]
24 Sep 2018, 2:29 pm by Anushka Limaye
Amidst a wave of U.S. tariffs on Chinese goods, a few items key to U.S. manufacturers have been provided exemptions, such as ibuprofen (90 percent of which comes from China). [read post]